打印本文 打印本文 关闭窗口 关闭窗口
年龄相关性黄斑变性脉络膜新生血管治疗的几个重要问题
作者:陈有信  文章来源:协和眼科  点击数10406  更新时间:2008/1/5 12:21:43  文章录入:maojin  责任编辑:maojin

 

总之,AMD以及各种其他原因引起的CNV的治疗,目前有了很多突破,只要组合应用得当,治疗的效果是完全可以预期的。但是,要取得良好的治疗效果以及社会经济层面的效益,必须对CNV和各种治疗方法以及其疗效和安全性有一个正确的全面的了解,然后个体化的应用这些方法治疗患者,才能取得最满意的效果。

参考文献

1. Macular Photocoagulation Study Group: Argon laser photocoagulation for senile macular degeneration: Results of a randomized clinical trial. Arch Ophthalmol 100: 912-918, 1982.

2.Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with Verteporfin: one-year results of 2 randomised clinical trials—TAP report. Arch Ophthalmol 1999;117:1329–1345.

3. VIP Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration:two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-- Verteporfin in Photodynamic therapy Report 2. Am  J Ophthalmol, 2001, 131:541-560.

4.Guyer DR, Yannuzzi LA, Slakter JS, et al. Digital indocyanine green videoangiography of occult choroidal neovascularization. Ophthalmology. 1994 ,101(10):1727-35; discussion 1735-1737.

5.Pece A, Introini U, Bolognesi G, et al. Indocyanine green angiography (ICGA) in age-related macular degeneration with occult CNV. Ophthalmologica. 1998;212(5):295-300

6.Yannuzzi LA, Sorenson J, Spaide RF, et al. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina. 1990;10(1):1-8.

7.Yannuzzi LA, Negrão S, Iida T, et al. Retinal angiomatous proliferation in age-related macular degeneration.Retina. 2001;21(5):416-34.

8. Scassellati-Sforzolini B, Mariotti C, Bryan R, Yannuzzi LA, Giuliani M, Giovannini A.Polypoidal choroidal vasculopathy in Italy.Retina. 2001;21(2):121-125.

9. Lee WK, Park YH, Lee PY. Neovascularization associated with large retinal pigment epithelial detachment in elderly Korean patients: subdivision according to indocyanine green angiographic features.Jpn J Ophthalmol. 2007,51(3):216-23.

10. Maruko I, Iida T, Saito M,et al.Clinical characteristics of exudative age-related macular degeneration in Japanese patients.Am J Ophthalmol. 2007 ,(1):15-22.

11. Liu Y, Wen F, Huang S, et al.Subtype lesions of neovascular age-related macular degeneration in Chinese patients. Graefes Arch Clin Ophtalmol.2007, 245(10)1441-1445

12. Gomi F, Sawa M, Sakaguchi H,et al.Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy. Br J Ophthalmol. 2008,92(1):70-73.

13. Akaza E, Yuzawa M, Matsumoto Y,et al. Role of photodynamic therapy in polypoidal choroidal vasculopathy. Jpn J Ophthalmol. 2007,51(4):270-277

14. Boscia F, Parodi MB, Furino C, Reibaldi M, Sborgia C. Photodynamic therapy with verteporfin for retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol. 2006,244(10):1224-1232.

15. Kuroiwa S, Arai J, Gaun S, et al. Rapidly progressive scar formation after transpupillary thermotherapy in retinal angiomatous proliferation. Retina. 2003,23(3):417-20

16.Yang N, Fan CM , CK Ho.Review of first year result of photodynamic therapy on age-related macular degeneration in Chinese population.  Eye (2006) 20, 523–526.

17.陈有信,董方田,张承芬等.光动力疗法老年黄斑变性伴脉络膜新生血管膜一年疗效观察.中华眼底病杂志,2007, 43(1)9-12

18. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY; MARINA Study Group.Ranibizumab for neovascular age-related macular degeneration.N Engl J Med. 2006,355(14):1419-1431.

19.Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S; ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med.,355(14):1432-1444.

20. Wu L, Martínez-Castellanos MA, Quiroz-Mercado Het al. Twelve-month safety of intravitreal injections of bevacizumab (Avastin(R)): results of the Pan-American Collaborative Retina Study Group (PACORES).Graefes Arch Clin Exp Ophthalmol. 2008,246(1):81-87.

21.Heier JS, Boyer DS, Ciulla TA, et al. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study.Arch Ophthalmol. 2006,124(11):1532-1542.

22.Liggett PE, Colina J, Chaudhry NA,et al. Triple therapy of intravitreal triamcinolone, photodynamic therapy, and pegaptanib sodium for choroidal neovascularization. Am J Ophthalmol. 2006,42(6):1072-4.

23. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.Arch Ophthalmol. 2001,119(10):1417-1436.

24.Stolba U, Krebs I, Lamar PD, A, et al. Long term results after transpupillary thermotherapy in eyes with occult choroidal neovascularisation associated with age related macular degeneration: a prospective trial.Br J Ophthalmol. 2006 ,90(2):158-61

25.张承芬,李志清,董方田等.经瞳孔温热疗法治疗老年性黄斑变性合并中心凹下脉络膜新生血管. 中华眼底病杂志.2004,20,280-284

上一页  [1] [2] [3] [4] [5] 

打印本文 打印本文 关闭窗口 关闭窗口